TIM
AERI

Thompson Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History

Thompson Investment Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-74,712
Closed -$1.13M – 188
2022
Q3 		$1.13M Hold
74,712
– – 0.22% 96
2022
Q2 		$560K Hold
74,712
– – 0.1% 124
2022
Q1 		$680K Hold
74,712
– – 0.1% 125
2021
Q4 		$524K Buy
74,712
+20,500
+38% +$215K 0.07% 151
2021
Q3 		$618K Buy
54,212
+21,807
+67% +$319K 0.09% 140
2021
Q2 		$519K Hold
32,405
– – 0.08% 147
2021
Q1 		$579K Hold
32,405
– – 0.09% 139
2020
Q4 		$438K Buy
32,405
+8,000
+33% +$96.7K 0.07% 139
2020
Q3 		$287K Hold
24,405
– – 0.05% 154
2020
Q2 		$360K Hold
24,405
– – 0.07% 144
2020
Q1 		$329K Hold
24,405
– – 0.07% 137
2019
Q4 		$590K Buy
24,405
+3,305
+16% +$68.5K 0.1% 120
2019
Q3 		$406K Buy
+21,100
New +$483K 0.08% 133

Thompson Investment Management's AERI Position: Q4 2022 in Review

Thompson Investment Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 74,712 shares — an estimated $1.13M sold.

Thompson Investment Management first reported a position in AERI in Q3 2019 and held it in 13 quarters. The position peaked at $1.13M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Thompson Investment Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Thompson Investment Management sold 74,712 Aerie Pharmaceuticals shares in Q4 2022, an estimated $1.13M.
  • Thompson Investment Management first reported a position in Aerie Pharmaceuticals in Q3 2019 and held it in 13 quarters.
  • Thompson Investment Management's Aerie Pharmaceuticals position peaked at $1.13M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Thompson Investment Management's 13F filing for Q4 2022, filed 20 Jan 2023.